GeneDx, a leader in delivering improved health outcomes through genomic insights, announced the appointment of Bryan Dechairo as Chief Operating Officer, effective immediately. In...
Immedica Pharma AB, a leading global rare disease company, and Marinus Pharmaceuticals, Inc, a pharmaceutical company committed to improving the lives of patients with...
Exicure, Inc, has announced the signing of a Memorandum of Understanding (MOU) with GPCR Therapeutics, Inc. on December 24, 2024, aimed at the acquisition...
Frost & Sullivan researched the bioinformatics-based drug discovery and development industry, and based on its analysis results, recognized DNAnexus, provider of the leading enterprise platform...
